Targeted Gene Delivery to MCF-7 Cells via Polyspermine-PEG-Glucose/DNA Nanoparticles: Preparation and Characterization
- PMID: 40473897
- DOI: 10.1007/s12033-025-01454-0
Targeted Gene Delivery to MCF-7 Cells via Polyspermine-PEG-Glucose/DNA Nanoparticles: Preparation and Characterization
Abstract
Cationic polymers are positively charged polymers that have a high ability to electrostatically interact with negatively charged species, including nucleic acids. This property has led to the use of these polymers in various fields, including targeted drug delivery. In this study, biocompatible polyspermine-polyethylene glycol (PEG)-glucose (PSPG) nanoparticles were synthesized for DNA delivery to MCF-7 cells. Structural characterization was performed via Fourier transform infrared spectroscopy (FTIR), hydrogen nuclear magnetic resonance spectroscopy (1HNMR), thermogravimetric analysis (TGA), and differential thermal gravimetric (DTG) methods. The DNA-loaded nanoparticles exhibited a spherical morphology with smooth surfaces, as confirmed by scanning electron microscopy (SEM) and transmission electron microscopy (TEM). Dynamic light scattering (DLS) revealed a particle size of 267 ± 10 nm and a surface charge of + 13.4 ± 1.3 mV. DNA release from PSPG was pH dependent, increasing at acidic pH (5.0, cancer cells) compared with physiological pH (7.4). The biocompatibility assessed via MTT demonstrated high gene transfer efficiency with minimal cytotoxicity. Agarose gel electrophoresis confirmed the protection of the DNA against enzymatic degradation. Gene delivery to MCF-7 cells was validated via fluorescence microscopy and flow cytometry, confirming successful transfection. These findings highlight the potential of polyspermine-PEG-glucose nanoparticles as efficient DNA carriers for targeted cancer therapy.
Keywords: DNA; Gastric cancer cells; Glucose; Polyspermine; Targeted gene transfer.
© 2025. The Author(s), under exclusive licence to Springer Science+Business Media, LLC, part of Springer Nature.
Conflict of interest statement
Declarations. Competing Interests: The authors declare that they have no conflicts of interest. Ethical Approval: This article does not contain any studies with human participants or animals performed by any of the authors. Consent to Participate: Not applicable. Consent for Publication: Not applicable.
Similar articles
-
Chitosan and chitosan/PEG nanoparticles loaded with indole-3-carbinol: Characterization, computational study and potential effect on human bladder cancer cells.Mater Sci Eng C Mater Biol Appl. 2021 May;124:112089. doi: 10.1016/j.msec.2021.112089. Epub 2021 Mar 31. Mater Sci Eng C Mater Biol Appl. 2021. PMID: 33947529
-
Spermine-alt-poly(ethylene glycol) polyspermine as a safe and efficient aerosol gene carrier for lung cancer therapy.J Biomed Mater Res A. 2014 Jul;102(7):2230-7. doi: 10.1002/jbm.a.34905. Epub 2013 Aug 13. J Biomed Mater Res A. 2014. PMID: 23929634
-
Design and synthesis of multi-targeted nanoparticles for gene delivery to breast cancer tissues.Naunyn Schmiedebergs Arch Pharmacol. 2023 Jan;396(1):121-137. doi: 10.1007/s00210-022-02303-6. Epub 2022 Oct 18. Naunyn Schmiedebergs Arch Pharmacol. 2023. PMID: 36255459
-
Effects of the incorporation of a hydrophobic middle block into a PEG-polycation diblock copolymer on the physicochemical and cell interaction properties of the polymer-DNA complexes.Biomacromolecules. 2008 Nov;9(11):3294-307. doi: 10.1021/bm800876v. Epub 2008 Oct 23. Biomacromolecules. 2008. PMID: 18942877 Free PMC article.
-
Thermo- and pH-responsive targeted lipid-coated mesoporous nano silica platform for dual delivery of paclitaxel and gemcitabine to overcome HER2-positive breast cancer.Int J Pharm. 2023 Dec 15;648:123606. doi: 10.1016/j.ijpharm.2023.123606. Epub 2023 Nov 14. Int J Pharm. 2023. PMID: 37972671
References
-
- Hamimed, S., Jabberi, M., & Chatti, A. (2022). Nanotechnology in drug and gene delivery. Naunyn-schmiedeberg’s Archives of Pharmacology, 395, 769–787. https://doi.org/10.1007/s00210-022-02245-z - DOI - PubMed - PMC
-
- Cring, M. R., & Sheffield, V. C. (2022). Gene therapy and gene correction: Targets, progress, and challenges for treating human diseases. Gene therapy, 29, 3–12. https://doi.org/10.1038/s41434-020-00197-8 - DOI - PubMed
-
- Paunovska, K., Loughrey, D., & Dahlman, J. E. (2022). Drug delivery systems for RNA therapeutics. Nature Reviews Genetics, 23, 265–280. https://doi.org/10.1038/s41576-021-00439-4 - DOI - PubMed - PMC
-
- Waseem, M., Naveed, M., Rehman, S. U., Makhdoom, S. I., Aziz, T., Alharbi, M., Alsahammari, A., & Alasmari, A. F. (2023). Molecular characterization of spa, hld, fmhA, and l ukD genes and computational modeling the multidrug resistance of staphylococcus species through Callindra Harrisii silver nanoparticles. ACS Omega, 8, 20920–20936. https://doi.org/10.1021/acsomega.3c01597 - DOI - PubMed - PMC
-
- Hajebi, S., Yousefiasl, S., Rahimmanesh, I., Dahim, A., Ahmadi, S., Kadumudi, F. B., Rahgozar, N., Amani, S., Kumar, A., & Kamrani, E. (2022). Genetically engineered viral vectors and organic-based non-viral nanocarriers for drug delivery applications. Advanced Healthcare Materials, 11, 2201583. https://doi.org/10.1002/adhm.202201583 - DOI - PubMed - PMC
LinkOut - more resources
Full Text Sources